Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

DECR2 Activators

The activation of DECR2 through indirect means would involve influencing the expression and function of this protein via the modulation of cellular signaling pathways, particularly those regulated by PPARs. PPARs are nuclear hormone receptors that, when activated, can induce the transcription of genes involved in lipid metabolism, including those encoding enzymes for the peroxisomal beta-oxidation pathway. Substances like fibrates (e.g., bezafibrate, fenofibrate, clofibrate, and gemfibrozil) are known to be potent activators of PPARα, leading to increased transcription of peroxisomal enzymes, potentially resulting in elevated DECR2 levels and activity. The specific action of fibrates involves their binding to PPARα, which heterodimerizes with the retinoid X receptor (RXR) and binds to peroxisome proliferator response elements (PPREs) in the promoter region of target genes, promoting their expression.

Moreover, fatty acids and their derivatives can serve as natural ligands for PPARs. Compounds like leukotriene B4, palmitic acid, linoleic acid, oleic acid, α-linolenic acid, and docosahexaenoic acid can modulate the activity of PPARs and thereby influence the expression of DECR2. The role of PPARs in peroxisomal proliferation and beta-oxidation is significant, as activation of these receptors upregulates the entire pathway, which includes the augmentation of DECR2 activity.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bezafibrate

41859-67-0sc-204650B
sc-204650
sc-204650A
sc-204650C
500 mg
1 g
5 g
10 g
$31.00
$46.00
$122.00
$204.00
5
(1)

Bezafibrate is a peroxisome proliferator-activated receptor (PPAR) agonist that can induce peroxisome proliferation, thereby potentially increasing the expression of peroxisomal enzymes including DECR2.

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

Fenofibrate, another PPAR agonist, can similarly lead to the induction of genes encoding for enzymes involved in fatty acid oxidation, which could enhance the levels and activity of DECR2.

Clofibrate

637-07-0sc-200721
1 g
$33.00
(1)

Clofibrate is also known to act on PPARs and could contribute to the upregulation of peroxisomal enzymes, possibly resulting in elevated DECR2 activity.

LTB4 (Leukotriene B4)

71160-24-2sc-201043
50 µg
$374.00
4
(1)

Leukotriene B4 is a fatty acid derivative that can act as a PPARα agonist, leading to the transcription of peroxisomal enzymes and could increase DECR2 activity.

WY 14643

50892-23-4sc-203314
50 mg
$136.00
7
(1)

Wy-14643 is a potent PPARα activator that can promote the expression of enzymes involved in the peroxisomal beta-oxidation pathway, thereby potentially enhancing DECR2 activity.

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$66.00
$267.00
2
(2)

Gemfibrozil acts as a PPARα agonist, which may result in the induction of fatty acid metabolism enzymes in peroxisomes, including DECR2.

L-Tyrosine

60-18-4sc-473512
sc-473512A
sc-473512B
sc-473512C
100 g
250 g
1 kg
5 kg
$52.00
$213.00
$1670.00
$8328.00
1
(1)

This compound has been shown to act as a PPAR agonist, potentially inducing the expression of DECR2 as part of the peroxisomal enzyme repertoire.

Palmitic Acid

57-10-3sc-203175
sc-203175A
25 g
100 g
$114.00
$286.00
2
(0)

Palmitic acid is a fatty acid that, at specific concentrations, can enhance peroxisomal proliferation and could, therefore, increase DECR2 expression as part of the overall upregulation of fatty acid metabolism.

Linoleic Acid

60-33-3sc-200788
sc-200788A
sc-200788B
sc-200788C
100 mg
1 g
5 g
25 g
$34.00
$64.00
$166.00
$281.00
4
(2)

Linoleic acid, a polyunsaturated fatty acid, might enhance the transcription of genes coding for peroxisomal enzymes through PPAR activation, thereby potentially increasing DECR2 activity.

Oleic Acid

112-80-1sc-200797C
sc-200797
sc-200797A
sc-200797B
1 g
10 g
100 g
250 g
$37.00
$104.00
$580.00
$1196.00
10
(1)

Oleic acid is a monounsaturated fatty acid that could lead to the activation of peroxisomal gene expression, possibly including DECR2, as a component of the cellular response to changes in lipid composition.